Fluorocarbon Nanodroplet Stability via Microfluidic Surfactant Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Perfluorocarbon nanodroplets used in diagnostic and therapeutic applications face challenges due to their limited physico-chemical stability, which affects their performance in ultrasound imaging and therapeutic delivery.
Innovation Solution
Calibrated (per)fluorocarbon nanodroplets are stabilized by biocompatible fluorinated surfactants using a microfluidic technique, with a higher molar ratio of surfactant to fluorocarbon, resulting in improved stability and uniform size distribution, enhancing their performance in ultrasound imaging and therapeutic applications.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional preparation methods (sonication, vortex, homogenization) are used to produce perfluorocarbon nanodroplets, then the manufacturing process is simple and accessible, but the nanodroplets exhibit limited physico-chemical stability and poor size uniformity
Solution Approach 1:
The patent replaces conventional mechanical preparation methods (sonication, vortex mixing, homogenization) with a microfluidic system that uses controlled fluid flow and pressure gradients to generate nanodroplets. This substitution enables precise control over droplet formation through laminar flow mixing and pressure-driven emulsification, resulting in improved size uniformity and stability without relying on harsh mechanical forces that compromise nanodroplet integrity
Solution Approach 2:
The patent systematically optimizes critical parameters including flow rates of aqueous and organic phases, pressure gradients across the microfluidic device, surfactant concentration, and temperature control. By precisely adjusting these parameters, the system achieves monodisperse nanodroplet formation with controlled size distribution and enhanced physico-chemical stability, transforming the preparation process from a粗放 (rough) mechanical approach to a precision-controlled fluidic system
2Productivity
If polydisperse nanodroplet suspensions are used, then the manufacturing process is simpler, but the vaporization efficiency is reduced due to varied acoustic responses
Solution Approach 1:
The patent employs a microfluidic device with segmented flow channels that divide the continuous phase into discrete droplet formations. The staggered herringbone mixer structure segments the fluid flow into controlled laminar streams, enabling individual nanodroplet nucleation and growth in isolated micro-environments. This segmentation ensures uniform size distribution while maintaining high production throughput through continuous flow processing
Solution Approach 2:
The patent controls droplet size uniformity by adjusting flow rate ratios, pressure differentials, and channel geometry parameters. By optimizing these parameters, the system produces monodisperse nanodroplets with narrow size distribution (PDI < 0.1), ensuring consistent acoustic vaporization response while maintaining manufacturing efficiency through scalable continuous production
3Quantity of substance
If low molar ratio of surfactant to fluorocarbon is used, then the material cost and surfactant quantity are reduced, but the nanodroplet stability deteriorates
Solution Approach 1:
The patent optimizes the surfactant-to-fluorocarbon molar ratio to achieve maximum stabilization efficiency. By systematically varying this parameter and characterizing nanodroplet stability, the invention identifies the optimal ratio that provides sufficient surface coverage and interfacial stabilization while minimizing surfactant consumption and associated costs
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The use of biocompatible fluorinated surfactants with a higher molar ratio in microfluidically prepared nanodroplets improves stability and uniformity, leading to enhanced performance in ultrasound imaging and therapeutic applications by maintaining size consistency and stability over time.
Implementation Method 1
mixing said aqueous phase and said organic phase in a mixing device of the microfluidic apparatus
Implementation Method 2
stabilized by biocompatible fluorinated surfactants
Implementation Method 3
nanodroplet comprising an outer layer and an inner core, said outer layer comprising a biocompatible fluorinated surfactant and said inner core comprising a fluorocarbon
Implementation Method 4
Owing to Acoustic Droplet Vaporization (ADV) process, encapsulated droplets are converted into gas bubbles upon exposure to ultrasound energy beyond a vaporization threshold
Data Source
AI summary
The present invention relates to calibrated (per)fluorocarbon nanodroplets comprising an outer layer and an inner core, said outer layer comprising a biocompatible fluorinated surfactant and said inner core comprising a (per)fluorocarbon. The invention further relates to a method of preparation of said calibrated (per)fluorocarbon nanodroplets through microfluidic technique, and to their use for in vivo or in vitro diagnostic and/or for therapy.